nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimipramine—HTR3A—Memantine—Alzheimer's disease	0.146	0.341	CbGbCtD
Trimipramine—SLC6A4—Alzheimer's disease	0.136	0.405	CbGaD
Trimipramine—HTR2A—Alzheimer's disease	0.105	0.311	CbGaD
Trimipramine—CYP2D6—Alzheimer's disease	0.0959	0.284	CbGaD
Trimipramine—HTR2A—Donepezil—Alzheimer's disease	0.0683	0.16	CbGbCtD
Trimipramine—DRD2—Memantine—Alzheimer's disease	0.0546	0.128	CbGbCtD
Trimipramine—CYP2D6—Rivastigmine—Alzheimer's disease	0.0284	0.0665	CbGbCtD
Trimipramine—CYP2C19—Memantine—Alzheimer's disease	0.0259	0.0607	CbGbCtD
Trimipramine—CYP2C9—Donepezil—Alzheimer's disease	0.0248	0.0582	CbGbCtD
Trimipramine—CYP2D6—Donepezil—Alzheimer's disease	0.0227	0.0532	CbGbCtD
Trimipramine—CYP3A4—Rivastigmine—Alzheimer's disease	0.0181	0.0423	CbGbCtD
Trimipramine—CYP2D6—Galantamine—Alzheimer's disease	0.0146	0.0343	CbGbCtD
Trimipramine—CYP3A4—Donepezil—Alzheimer's disease	0.0144	0.0338	CbGbCtD
Trimipramine—CYP3A4—Galantamine—Alzheimer's disease	0.00931	0.0218	CbGbCtD
Trimipramine—HTR2C—choroid plexus—Alzheimer's disease	0.00779	0.13	CbGeAlD
Trimipramine—SLC6A2—locus ceruleus—Alzheimer's disease	0.00402	0.0672	CbGeAlD
Trimipramine—HTR2A—choroid plexus—Alzheimer's disease	0.00391	0.0654	CbGeAlD
Trimipramine—HTR2A—locus ceruleus—Alzheimer's disease	0.00242	0.0404	CbGeAlD
Trimipramine—SLC6A3—telencephalic ventricle—Alzheimer's disease	0.00236	0.0395	CbGeAlD
Trimipramine—HTR1D—telencephalic ventricle—Alzheimer's disease	0.00231	0.0386	CbGeAlD
Trimipramine—HTR2C—telencephalic ventricle—Alzheimer's disease	0.00228	0.0382	CbGeAlD
Trimipramine—Epigastric distress—Donepezil—Alzheimer's disease	0.00219	0.0205	CcSEcCtD
Trimipramine—HTR2A—cerebellar cortex—Alzheimer's disease	0.00197	0.0329	CbGeAlD
Trimipramine—HTR1A—telencephalic ventricle—Alzheimer's disease	0.00192	0.0322	CbGeAlD
Trimipramine—DRD2—telencephalic ventricle—Alzheimer's disease	0.00174	0.0291	CbGeAlD
Trimipramine—Block heart—Donepezil—Alzheimer's disease	0.0015	0.014	CcSEcCtD
Trimipramine—Extrapyramidal symptoms—Rivastigmine—Alzheimer's disease	0.00146	0.0136	CcSEcCtD
Trimipramine—Block heart—Memantine—Alzheimer's disease	0.00136	0.0127	CcSEcCtD
Trimipramine—Inappropriate antidiuretic hormone secretion—Memantine—Alzheimer's disease	0.00133	0.0124	CcSEcCtD
Trimipramine—Delusion—Donepezil—Alzheimer's disease	0.0012	0.0112	CcSEcCtD
Trimipramine—Throat sore—Donepezil—Alzheimer's disease	0.00118	0.011	CcSEcCtD
Trimipramine—Oropharyngeal discomfort—Donepezil—Alzheimer's disease	0.00117	0.0109	CcSEcCtD
Trimipramine—HTR2A—telencephalic ventricle—Alzheimer's disease	0.00115	0.0192	CbGeAlD
Trimipramine—HTR1D—blood vessel—Alzheimer's disease	0.00114	0.0191	CbGeAlD
Trimipramine—Atrioventricular block—Galantamine—Alzheimer's disease	0.00113	0.0106	CcSEcCtD
Trimipramine—Extrapyramidal disorder—Donepezil—Alzheimer's disease	0.00113	0.0105	CcSEcCtD
Trimipramine—Delusion—Memantine—Alzheimer's disease	0.00109	0.0102	CcSEcCtD
Trimipramine—Delusion—Rivastigmine—Alzheimer's disease	0.00107	0.00996	CcSEcCtD
Trimipramine—Nightmare—Galantamine—Alzheimer's disease	0.00106	0.00989	CcSEcCtD
Trimipramine—Numbness—Donepezil—Alzheimer's disease	0.00103	0.00957	CcSEcCtD
Trimipramine—Extrapyramidal disorder—Memantine—Alzheimer's disease	0.00103	0.00957	CcSEcCtD
Trimipramine—Extrapyramidal disorder—Rivastigmine—Alzheimer's disease	0.001	0.00936	CcSEcCtD
Trimipramine—Sensory loss—Donepezil—Alzheimer's disease	0.000981	0.00916	CcSEcCtD
Trimipramine—Oropharyngeal pain—Donepezil—Alzheimer's disease	0.000935	0.00873	CcSEcCtD
Trimipramine—Numbness—Memantine—Alzheimer's disease	0.000931	0.00869	CcSEcCtD
Trimipramine—Sensory loss—Memantine—Alzheimer's disease	0.000891	0.00832	CcSEcCtD
Trimipramine—Vascular purpura—Galantamine—Alzheimer's disease	0.00089	0.00831	CcSEcCtD
Trimipramine—Atrioventricular block—Donepezil—Alzheimer's disease	0.000876	0.00818	CcSEcCtD
Trimipramine—Purpura—Galantamine—Alzheimer's disease	0.000826	0.00771	CcSEcCtD
Trimipramine—Cerebrovascular accident—Galantamine—Alzheimer's disease	0.000813	0.00759	CcSEcCtD
Trimipramine—Atrioventricular block—Memantine—Alzheimer's disease	0.000796	0.00743	CcSEcCtD
Trimipramine—Disturbance in sexual arousal—Galantamine—Alzheimer's disease	0.00079	0.00738	CcSEcCtD
Trimipramine—Coordination abnormal—Memantine—Alzheimer's disease	0.000786	0.00734	CcSEcCtD
Trimipramine—Atrioventricular block—Rivastigmine—Alzheimer's disease	0.000778	0.00727	CcSEcCtD
Trimipramine—Coordination abnormal—Rivastigmine—Alzheimer's disease	0.000769	0.00718	CcSEcCtD
Trimipramine—Urinary retention—Galantamine—Alzheimer's disease	0.000757	0.00707	CcSEcCtD
Trimipramine—Ataxia—Galantamine—Alzheimer's disease	0.000749	0.00699	CcSEcCtD
Trimipramine—Nightmare—Memantine—Alzheimer's disease	0.000745	0.00696	CcSEcCtD
Trimipramine—HTR3A—forebrain—Alzheimer's disease	0.000741	0.0124	CbGeAlD
Trimipramine—Nightmare—Rivastigmine—Alzheimer's disease	0.000729	0.00681	CcSEcCtD
Trimipramine—HTR3A—telencephalon—Alzheimer's disease	0.000682	0.0114	CbGeAlD
Trimipramine—Libido decreased—Donepezil—Alzheimer's disease	0.000665	0.00621	CcSEcCtD
Trimipramine—Pollakiuria—Galantamine—Alzheimer's disease	0.000636	0.00594	CcSEcCtD
Trimipramine—Cerebrovascular accident—Donepezil—Alzheimer's disease	0.00063	0.00588	CcSEcCtD
Trimipramine—Vascular purpura—Memantine—Alzheimer's disease	0.000626	0.00585	CcSEcCtD
Trimipramine—Disorientation—Memantine—Alzheimer's disease	0.000626	0.00585	CcSEcCtD
Trimipramine—SLC6A3—forebrain—Alzheimer's disease	0.000617	0.0103	CbGeAlD
Trimipramine—Vascular purpura—Rivastigmine—Alzheimer's disease	0.000613	0.00572	CcSEcCtD
Trimipramine—Disturbance in sexual arousal—Donepezil—Alzheimer's disease	0.000612	0.00572	CcSEcCtD
Trimipramine—Libido decreased—Memantine—Alzheimer's disease	0.000604	0.00564	CcSEcCtD
Trimipramine—Psychotic disorder—Donepezil—Alzheimer's disease	0.000603	0.00563	CcSEcCtD
Trimipramine—HTR1D—forebrain—Alzheimer's disease	0.000602	0.0101	CbGeAlD
Trimipramine—Neuropathy peripheral—Galantamine—Alzheimer's disease	0.000601	0.00562	CcSEcCtD
Trimipramine—HTR2C—forebrain—Alzheimer's disease	0.000596	0.00998	CbGeAlD
Trimipramine—Libido decreased—Rivastigmine—Alzheimer's disease	0.000591	0.00552	CcSEcCtD
Trimipramine—Urinary retention—Donepezil—Alzheimer's disease	0.000587	0.00548	CcSEcCtD
Trimipramine—Purpura—Memantine—Alzheimer's disease	0.000581	0.00543	CcSEcCtD
Trimipramine—Ataxia—Donepezil—Alzheimer's disease	0.00058	0.00542	CcSEcCtD
Trimipramine—Cerebrovascular accident—Memantine—Alzheimer's disease	0.000572	0.00534	CcSEcCtD
Trimipramine—Purpura—Rivastigmine—Alzheimer's disease	0.000569	0.00531	CcSEcCtD
Trimipramine—SLC6A3—telencephalon—Alzheimer's disease	0.000567	0.00949	CbGeAlD
Trimipramine—HTR2A—blood vessel—Alzheimer's disease	0.000567	0.00948	CbGeAlD
Trimipramine—SLC6A4—forebrain—Alzheimer's disease	0.000565	0.00946	CbGeAlD
Trimipramine—Cerebrovascular accident—Rivastigmine—Alzheimer's disease	0.000559	0.00522	CcSEcCtD
Trimipramine—Disturbance in sexual arousal—Memantine—Alzheimer's disease	0.000556	0.00519	CcSEcCtD
Trimipramine—HTR1D—telencephalon—Alzheimer's disease	0.000554	0.00926	CbGeAlD
Trimipramine—HTR2C—telencephalon—Alzheimer's disease	0.000548	0.00917	CbGeAlD
Trimipramine—Hallucination—Galantamine—Alzheimer's disease	0.000548	0.00512	CcSEcCtD
Trimipramine—Psychotic disorder—Memantine—Alzheimer's disease	0.000547	0.00511	CcSEcCtD
Trimipramine—Disturbance in sexual arousal—Rivastigmine—Alzheimer's disease	0.000544	0.00508	CcSEcCtD
Trimipramine—Psychotic disorder—Rivastigmine—Alzheimer's disease	0.000535	0.005	CcSEcCtD
Trimipramine—Urinary retention—Memantine—Alzheimer's disease	0.000533	0.00497	CcSEcCtD
Trimipramine—Eosinophilia—Donepezil—Alzheimer's disease	0.000528	0.00493	CcSEcCtD
Trimipramine—Ataxia—Memantine—Alzheimer's disease	0.000527	0.00492	CcSEcCtD
Trimipramine—Urinary retention—Rivastigmine—Alzheimer's disease	0.000521	0.00487	CcSEcCtD
Trimipramine—SLC6A4—telencephalon—Alzheimer's disease	0.00052	0.0087	CbGeAlD
Trimipramine—Ataxia—Rivastigmine—Alzheimer's disease	0.000515	0.00481	CcSEcCtD
Trimipramine—Tinnitus—Galantamine—Alzheimer's disease	0.000514	0.0048	CcSEcCtD
Trimipramine—Flushing—Galantamine—Alzheimer's disease	0.000511	0.00477	CcSEcCtD
Trimipramine—HTR1A—forebrain—Alzheimer's disease	0.000502	0.0084	CbGeAlD
Trimipramine—SLC6A2—forebrain—Alzheimer's disease	0.000498	0.00833	CbGeAlD
Trimipramine—Pollakiuria—Donepezil—Alzheimer's disease	0.000493	0.0046	CcSEcCtD
Trimipramine—Arrhythmia—Galantamine—Alzheimer's disease	0.000492	0.00459	CcSEcCtD
Trimipramine—Weight increased—Donepezil—Alzheimer's disease	0.000485	0.00453	CcSEcCtD
Trimipramine—Dysgeusia—Galantamine—Alzheimer's disease	0.00047	0.00438	CcSEcCtD
Trimipramine—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.000469	0.00438	CcSEcCtD
Trimipramine—Myocardial infarction—Donepezil—Alzheimer's disease	0.000466	0.00435	CcSEcCtD
Trimipramine—Jaundice—Donepezil—Alzheimer's disease	0.000464	0.00433	CcSEcCtD
Trimipramine—ADRA1A—forebrain—Alzheimer's disease	0.000463	0.00774	CbGeAlD
Trimipramine—HTR1A—telencephalon—Alzheimer's disease	0.000461	0.00772	CbGeAlD
Trimipramine—Pancytopenia—Memantine—Alzheimer's disease	0.00046	0.00429	CcSEcCtD
Trimipramine—SLC6A2—telencephalon—Alzheimer's disease	0.000458	0.00766	CbGeAlD
Trimipramine—DRD2—forebrain—Alzheimer's disease	0.000453	0.00759	CbGeAlD
Trimipramine—Vision blurred—Galantamine—Alzheimer's disease	0.000452	0.00422	CcSEcCtD
Trimipramine—Tremor—Galantamine—Alzheimer's disease	0.000449	0.00419	CcSEcCtD
Trimipramine—Pollakiuria—Memantine—Alzheimer's disease	0.000447	0.00418	CcSEcCtD
Trimipramine—ADRA1B—nervous system—Alzheimer's disease	0.000447	0.00748	CbGeAlD
Trimipramine—Erectile dysfunction—Memantine—Alzheimer's disease	0.000446	0.00416	CcSEcCtD
Trimipramine—Ill-defined disorder—Galantamine—Alzheimer's disease	0.000445	0.00415	CcSEcCtD
Trimipramine—Weight increased—Memantine—Alzheimer's disease	0.000441	0.00411	CcSEcCtD
Trimipramine—Agitation—Galantamine—Alzheimer's disease	0.000441	0.00411	CcSEcCtD
Trimipramine—Pollakiuria—Rivastigmine—Alzheimer's disease	0.000438	0.00409	CcSEcCtD
Trimipramine—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.000436	0.00407	CcSEcCtD
Trimipramine—Malaise—Galantamine—Alzheimer's disease	0.000432	0.00404	CcSEcCtD
Trimipramine—Weight increased—Rivastigmine—Alzheimer's disease	0.000431	0.00403	CcSEcCtD
Trimipramine—ADRA1B—central nervous system—Alzheimer's disease	0.00043	0.0072	CbGeAlD
Trimipramine—Acute coronary syndrome—Memantine—Alzheimer's disease	0.000426	0.00397	CcSEcCtD
Trimipramine—ADRA1A—telencephalon—Alzheimer's disease	0.000425	0.00712	CbGeAlD
Trimipramine—Hypoaesthesia—Donepezil—Alzheimer's disease	0.000425	0.00397	CcSEcCtD
Trimipramine—Hallucination—Donepezil—Alzheimer's disease	0.000425	0.00397	CcSEcCtD
Trimipramine—Palpitations—Galantamine—Alzheimer's disease	0.000424	0.00396	CcSEcCtD
Trimipramine—Neuropathy peripheral—Memantine—Alzheimer's disease	0.000423	0.00395	CcSEcCtD
Trimipramine—Myocardial infarction—Memantine—Alzheimer's disease	0.000423	0.00395	CcSEcCtD
Trimipramine—Drowsiness—Rivastigmine—Alzheimer's disease	0.000422	0.00394	CcSEcCtD
Trimipramine—DRD2—telencephalon—Alzheimer's disease	0.000417	0.00698	CbGeAlD
Trimipramine—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.000416	0.00389	CcSEcCtD
Trimipramine—Convulsion—Galantamine—Alzheimer's disease	0.000415	0.00388	CcSEcCtD
Trimipramine—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.000414	0.00387	CcSEcCtD
Trimipramine—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.000414	0.00387	CcSEcCtD
Trimipramine—Hypertension—Galantamine—Alzheimer's disease	0.000414	0.00387	CcSEcCtD
Trimipramine—Anxiety—Galantamine—Alzheimer's disease	0.000407	0.0038	CcSEcCtD
Trimipramine—Discomfort—Galantamine—Alzheimer's disease	0.000403	0.00377	CcSEcCtD
Trimipramine—Agranulocytosis—Memantine—Alzheimer's disease	0.000403	0.00376	CcSEcCtD
Trimipramine—HTR3A—nervous system—Alzheimer's disease	0.000402	0.00673	CbGeAlD
Trimipramine—Dry mouth—Galantamine—Alzheimer's disease	0.000399	0.00373	CcSEcCtD
Trimipramine—Tinnitus—Donepezil—Alzheimer's disease	0.000398	0.00372	CcSEcCtD
Trimipramine—Confusional state—Galantamine—Alzheimer's disease	0.000395	0.00368	CcSEcCtD
Trimipramine—HTR3A—central nervous system—Alzheimer's disease	0.000387	0.00648	CbGeAlD
Trimipramine—Hypoaesthesia—Memantine—Alzheimer's disease	0.000386	0.0036	CcSEcCtD
Trimipramine—Hallucination—Memantine—Alzheimer's disease	0.000386	0.0036	CcSEcCtD
Trimipramine—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000383	0.00358	CcSEcCtD
Trimipramine—Tachycardia—Galantamine—Alzheimer's disease	0.000382	0.00357	CcSEcCtD
Trimipramine—Arrhythmia—Donepezil—Alzheimer's disease	0.000381	0.00356	CcSEcCtD
Trimipramine—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000377	0.00352	CcSEcCtD
Trimipramine—Hallucination—Rivastigmine—Alzheimer's disease	0.000377	0.00352	CcSEcCtD
Trimipramine—Alopecia—Donepezil—Alzheimer's disease	0.000377	0.00352	CcSEcCtD
Trimipramine—Anorexia—Galantamine—Alzheimer's disease	0.000373	0.00348	CcSEcCtD
Trimipramine—ABCB1—blood vessel—Alzheimer's disease	0.000371	0.00622	CbGeAlD
Trimipramine—Hypotension—Galantamine—Alzheimer's disease	0.000366	0.00341	CcSEcCtD
Trimipramine—Dysgeusia—Donepezil—Alzheimer's disease	0.000364	0.0034	CcSEcCtD
Trimipramine—Tinnitus—Memantine—Alzheimer's disease	0.000361	0.00337	CcSEcCtD
Trimipramine—Flushing—Memantine—Alzheimer's disease	0.00036	0.00336	CcSEcCtD
Trimipramine—HRH1—forebrain—Alzheimer's disease	0.000358	0.00599	CbGeAlD
Trimipramine—Insomnia—Galantamine—Alzheimer's disease	0.000354	0.0033	CcSEcCtD
Trimipramine—Tinnitus—Rivastigmine—Alzheimer's disease	0.000354	0.0033	CcSEcCtD
Trimipramine—Flushing—Rivastigmine—Alzheimer's disease	0.000352	0.00329	CcSEcCtD
Trimipramine—ADRA2A—forebrain—Alzheimer's disease	0.000352	0.00588	CbGeAlD
Trimipramine—Paraesthesia—Galantamine—Alzheimer's disease	0.000351	0.00328	CcSEcCtD
Trimipramine—Vision blurred—Donepezil—Alzheimer's disease	0.00035	0.00327	CcSEcCtD
Trimipramine—Tremor—Donepezil—Alzheimer's disease	0.000348	0.00325	CcSEcCtD
Trimipramine—Somnolence—Galantamine—Alzheimer's disease	0.000348	0.00325	CcSEcCtD
Trimipramine—Arrhythmia—Memantine—Alzheimer's disease	0.000346	0.00323	CcSEcCtD
Trimipramine—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000345	0.00322	CcSEcCtD
Trimipramine—Dyspepsia—Galantamine—Alzheimer's disease	0.000344	0.00322	CcSEcCtD
Trimipramine—Alopecia—Memantine—Alzheimer's disease	0.000343	0.0032	CcSEcCtD
Trimipramine—ADRA1B—brain—Alzheimer's disease	0.000342	0.00572	CbGeAlD
Trimipramine—Agitation—Donepezil—Alzheimer's disease	0.000341	0.00319	CcSEcCtD
Trimipramine—Decreased appetite—Galantamine—Alzheimer's disease	0.00034	0.00318	CcSEcCtD
Trimipramine—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000339	0.00316	CcSEcCtD
Trimipramine—HTR2A—embryo—Alzheimer's disease	0.000338	0.00566	CbGeAlD
Trimipramine—Fatigue—Galantamine—Alzheimer's disease	0.000337	0.00315	CcSEcCtD
Trimipramine—Aprindine—CALM1—Alzheimer's disease	0.000336	0.0792	CrCbGaD
Trimipramine—Malaise—Donepezil—Alzheimer's disease	0.000335	0.00313	CcSEcCtD
Trimipramine—Alopecia—Rivastigmine—Alzheimer's disease	0.000335	0.00313	CcSEcCtD
Trimipramine—SLC6A3—nervous system—Alzheimer's disease	0.000335	0.0056	CbGeAlD
Trimipramine—Constipation—Galantamine—Alzheimer's disease	0.000335	0.00312	CcSEcCtD
Trimipramine—Dysgeusia—Memantine—Alzheimer's disease	0.00033	0.00309	CcSEcCtD
Trimipramine—Dimetacrine—ACHE—Alzheimer's disease	0.00033	0.0777	CrCbGaD
Trimipramine—HRH1—telencephalon—Alzheimer's disease	0.000329	0.00551	CbGeAlD
Trimipramine—HTR1D—nervous system—Alzheimer's disease	0.000327	0.00547	CbGeAlD
Trimipramine—HTR2C—nervous system—Alzheimer's disease	0.000324	0.00542	CbGeAlD
Trimipramine—ADRA2A—telencephalon—Alzheimer's disease	0.000323	0.00541	CbGeAlD
Trimipramine—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000323	0.00302	CcSEcCtD
Trimipramine—Feeling abnormal—Galantamine—Alzheimer's disease	0.000322	0.00301	CcSEcCtD
Trimipramine—SLC6A3—central nervous system—Alzheimer's disease	0.000322	0.00539	CbGeAlD
Trimipramine—Convulsion—Donepezil—Alzheimer's disease	0.000322	0.00301	CcSEcCtD
Trimipramine—Hypertension—Donepezil—Alzheimer's disease	0.000321	0.003	CcSEcCtD
Trimipramine—Vision blurred—Memantine—Alzheimer's disease	0.000318	0.00297	CcSEcCtD
Trimipramine—Tremor—Memantine—Alzheimer's disease	0.000316	0.00295	CcSEcCtD
Trimipramine—Anxiety—Donepezil—Alzheimer's disease	0.000315	0.00294	CcSEcCtD
Trimipramine—SLC6A3—cerebellum—Alzheimer's disease	0.000315	0.00527	CbGeAlD
Trimipramine—HTR1D—central nervous system—Alzheimer's disease	0.000315	0.00526	CbGeAlD
Trimipramine—Ill-defined disorder—Memantine—Alzheimer's disease	0.000313	0.00292	CcSEcCtD
Trimipramine—Discomfort—Donepezil—Alzheimer's disease	0.000313	0.00292	CcSEcCtD
Trimipramine—HTR2C—central nervous system—Alzheimer's disease	0.000312	0.00521	CbGeAlD
Trimipramine—Vision blurred—Rivastigmine—Alzheimer's disease	0.000311	0.0029	CcSEcCtD
Trimipramine—Agitation—Memantine—Alzheimer's disease	0.00031	0.0029	CcSEcCtD
Trimipramine—Dry mouth—Donepezil—Alzheimer's disease	0.000309	0.00289	CcSEcCtD
Trimipramine—Abdominal pain—Galantamine—Alzheimer's disease	0.000309	0.00289	CcSEcCtD
Trimipramine—Body temperature increased—Galantamine—Alzheimer's disease	0.000309	0.00289	CcSEcCtD
Trimipramine—Tremor—Rivastigmine—Alzheimer's disease	0.000309	0.00289	CcSEcCtD
Trimipramine—HTR3A—brain—Alzheimer's disease	0.000308	0.00515	CbGeAlD
Trimipramine—SLC6A4—nervous system—Alzheimer's disease	0.000307	0.00513	CbGeAlD
Trimipramine—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000306	0.00286	CcSEcCtD
Trimipramine—Confusional state—Donepezil—Alzheimer's disease	0.000306	0.00286	CcSEcCtD
Trimipramine—Malaise—Memantine—Alzheimer's disease	0.000304	0.00284	CcSEcCtD
Trimipramine—Agitation—Rivastigmine—Alzheimer's disease	0.000303	0.00283	CcSEcCtD
Trimipramine—Oedema—Donepezil—Alzheimer's disease	0.000303	0.00283	CcSEcCtD
Trimipramine—HTR2A—forebrain—Alzheimer's disease	0.000299	0.005	CbGeAlD
Trimipramine—Palpitations—Memantine—Alzheimer's disease	0.000298	0.00278	CcSEcCtD
Trimipramine—Malaise—Rivastigmine—Alzheimer's disease	0.000298	0.00278	CcSEcCtD
Trimipramine—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000297	0.00277	CcSEcCtD
Trimipramine—SLC6A4—central nervous system—Alzheimer's disease	0.000295	0.00494	CbGeAlD
Trimipramine—Convulsion—Memantine—Alzheimer's disease	0.000292	0.00273	CcSEcCtD
Trimipramine—Palpitations—Rivastigmine—Alzheimer's disease	0.000292	0.00272	CcSEcCtD
Trimipramine—Hypertension—Memantine—Alzheimer's disease	0.000291	0.00272	CcSEcCtD
Trimipramine—Anorexia—Donepezil—Alzheimer's disease	0.000289	0.0027	CcSEcCtD
Trimipramine—Anxiety—Memantine—Alzheimer's disease	0.000286	0.00267	CcSEcCtD
Trimipramine—Convulsion—Rivastigmine—Alzheimer's disease	0.000286	0.00267	CcSEcCtD
Trimipramine—Hypertension—Rivastigmine—Alzheimer's disease	0.000285	0.00266	CcSEcCtD
Trimipramine—Discomfort—Memantine—Alzheimer's disease	0.000284	0.00265	CcSEcCtD
Trimipramine—Hypotension—Donepezil—Alzheimer's disease	0.000283	0.00265	CcSEcCtD
Trimipramine—Dry mouth—Memantine—Alzheimer's disease	0.000281	0.00262	CcSEcCtD
Trimipramine—Asthenia—Galantamine—Alzheimer's disease	0.000281	0.00262	CcSEcCtD
Trimipramine—Anxiety—Rivastigmine—Alzheimer's disease	0.00028	0.00261	CcSEcCtD
Trimipramine—Confusional state—Memantine—Alzheimer's disease	0.000278	0.00259	CcSEcCtD
Trimipramine—Discomfort—Rivastigmine—Alzheimer's disease	0.000278	0.00259	CcSEcCtD
Trimipramine—Oedema—Memantine—Alzheimer's disease	0.000275	0.00257	CcSEcCtD
Trimipramine—HTR2A—telencephalon—Alzheimer's disease	0.000275	0.0046	CbGeAlD
Trimipramine—Dry mouth—Rivastigmine—Alzheimer's disease	0.000275	0.00257	CcSEcCtD
Trimipramine—Insomnia—Donepezil—Alzheimer's disease	0.000274	0.00256	CcSEcCtD
Trimipramine—CYP2D6—forebrain—Alzheimer's disease	0.000272	0.00456	CbGeAlD
Trimipramine—HTR1A—nervous system—Alzheimer's disease	0.000272	0.00456	CbGeAlD
Trimipramine—Paraesthesia—Donepezil—Alzheimer's disease	0.000272	0.00254	CcSEcCtD
Trimipramine—Confusional state—Rivastigmine—Alzheimer's disease	0.000272	0.00254	CcSEcCtD
Trimipramine—SLC6A2—nervous system—Alzheimer's disease	0.00027	0.00452	CbGeAlD
Trimipramine—Somnolence—Donepezil—Alzheimer's disease	0.00027	0.00252	CcSEcCtD
Trimipramine—Thrombocytopenia—Memantine—Alzheimer's disease	0.00027	0.00252	CcSEcCtD
Trimipramine—Oedema—Rivastigmine—Alzheimer's disease	0.000269	0.00252	CcSEcCtD
Trimipramine—Tachycardia—Memantine—Alzheimer's disease	0.000269	0.00251	CcSEcCtD
Trimipramine—Diarrhoea—Galantamine—Alzheimer's disease	0.000268	0.0025	CcSEcCtD
Trimipramine—Dyspepsia—Donepezil—Alzheimer's disease	0.000267	0.00249	CcSEcCtD
Trimipramine—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000264	0.00246	CcSEcCtD
Trimipramine—Decreased appetite—Donepezil—Alzheimer's disease	0.000264	0.00246	CcSEcCtD
Trimipramine—Tachycardia—Rivastigmine—Alzheimer's disease	0.000263	0.00245	CcSEcCtD
Trimipramine—Anorexia—Memantine—Alzheimer's disease	0.000262	0.00245	CcSEcCtD
Trimipramine—HTR1A—central nervous system—Alzheimer's disease	0.000262	0.00439	CbGeAlD
Trimipramine—Fatigue—Donepezil—Alzheimer's disease	0.000261	0.00244	CcSEcCtD
Trimipramine—SLC6A2—central nervous system—Alzheimer's disease	0.00026	0.00435	CbGeAlD
Trimipramine—Constipation—Donepezil—Alzheimer's disease	0.000259	0.00242	CcSEcCtD
Trimipramine—Dizziness—Galantamine—Alzheimer's disease	0.000259	0.00242	CcSEcCtD
Trimipramine—Hypotension—Memantine—Alzheimer's disease	0.000257	0.0024	CcSEcCtD
Trimipramine—Anorexia—Rivastigmine—Alzheimer's disease	0.000257	0.0024	CcSEcCtD
Trimipramine—HTR1A—cerebellum—Alzheimer's disease	0.000256	0.00429	CbGeAlD
Trimipramine—SLC6A3—brain—Alzheimer's disease	0.000256	0.00428	CbGeAlD
Trimipramine—Hypotension—Rivastigmine—Alzheimer's disease	0.000252	0.00235	CcSEcCtD
Trimipramine—ADRA1A—nervous system—Alzheimer's disease	0.000251	0.0042	CbGeAlD
Trimipramine—CYP2D6—telencephalon—Alzheimer's disease	0.000251	0.00419	CbGeAlD
Trimipramine—Feeling abnormal—Donepezil—Alzheimer's disease	0.00025	0.00233	CcSEcCtD
Trimipramine—HTR1D—brain—Alzheimer's disease	0.00025	0.00418	CbGeAlD
Trimipramine—Insomnia—Memantine—Alzheimer's disease	0.000249	0.00233	CcSEcCtD
Trimipramine—Vomiting—Galantamine—Alzheimer's disease	0.000249	0.00232	CcSEcCtD
Trimipramine—HTR2C—brain—Alzheimer's disease	0.000247	0.00414	CbGeAlD
Trimipramine—Paraesthesia—Memantine—Alzheimer's disease	0.000247	0.00231	CcSEcCtD
Trimipramine—Rash—Galantamine—Alzheimer's disease	0.000247	0.0023	CcSEcCtD
Trimipramine—Dermatitis—Galantamine—Alzheimer's disease	0.000247	0.0023	CcSEcCtD
Trimipramine—DRD2—nervous system—Alzheimer's disease	0.000246	0.00412	CbGeAlD
Trimipramine—Headache—Galantamine—Alzheimer's disease	0.000245	0.00229	CcSEcCtD
Trimipramine—Somnolence—Memantine—Alzheimer's disease	0.000245	0.00229	CcSEcCtD
Trimipramine—Insomnia—Rivastigmine—Alzheimer's disease	0.000244	0.00227	CcSEcCtD
Trimipramine—Dyspepsia—Memantine—Alzheimer's disease	0.000242	0.00226	CcSEcCtD
Trimipramine—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000242	0.00226	CcSEcCtD
Trimipramine—ADRA1A—central nervous system—Alzheimer's disease	0.000242	0.00405	CbGeAlD
Trimipramine—Urticaria—Donepezil—Alzheimer's disease	0.000241	0.00225	CcSEcCtD
Trimipramine—Body temperature increased—Donepezil—Alzheimer's disease	0.00024	0.00224	CcSEcCtD
Trimipramine—Abdominal pain—Donepezil—Alzheimer's disease	0.00024	0.00224	CcSEcCtD
Trimipramine—Somnolence—Rivastigmine—Alzheimer's disease	0.000239	0.00224	CcSEcCtD
Trimipramine—Decreased appetite—Memantine—Alzheimer's disease	0.000239	0.00224	CcSEcCtD
Trimipramine—Fatigue—Memantine—Alzheimer's disease	0.000237	0.00222	CcSEcCtD
Trimipramine—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000237	0.00221	CcSEcCtD
Trimipramine—DRD2—central nervous system—Alzheimer's disease	0.000237	0.00397	CbGeAlD
Trimipramine—ADRA1A—cerebellum—Alzheimer's disease	0.000236	0.00395	CbGeAlD
Trimipramine—Constipation—Memantine—Alzheimer's disease	0.000235	0.0022	CcSEcCtD
Trimipramine—SLC6A4—brain—Alzheimer's disease	0.000235	0.00392	CbGeAlD
Trimipramine—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000234	0.00219	CcSEcCtD
Trimipramine—Nausea—Galantamine—Alzheimer's disease	0.000232	0.00217	CcSEcCtD
Trimipramine—Fatigue—Rivastigmine—Alzheimer's disease	0.000232	0.00217	CcSEcCtD
Trimipramine—DRD2—cerebellum—Alzheimer's disease	0.000232	0.00388	CbGeAlD
Trimipramine—Constipation—Rivastigmine—Alzheimer's disease	0.00023	0.00215	CcSEcCtD
Trimipramine—Feeling abnormal—Memantine—Alzheimer's disease	0.000227	0.00212	CcSEcCtD
Trimipramine—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000222	0.00207	CcSEcCtD
Trimipramine—ABCB1—embryo—Alzheimer's disease	0.000222	0.00371	CbGeAlD
Trimipramine—Urticaria—Memantine—Alzheimer's disease	0.000219	0.00204	CcSEcCtD
Trimipramine—Abdominal pain—Memantine—Alzheimer's disease	0.000218	0.00203	CcSEcCtD
Trimipramine—Body temperature increased—Memantine—Alzheimer's disease	0.000218	0.00203	CcSEcCtD
Trimipramine—Asthenia—Donepezil—Alzheimer's disease	0.000218	0.00203	CcSEcCtD
Trimipramine—Pruritus—Donepezil—Alzheimer's disease	0.000215	0.002	CcSEcCtD
Trimipramine—Urticaria—Rivastigmine—Alzheimer's disease	0.000214	0.002	CcSEcCtD
Trimipramine—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000213	0.00199	CcSEcCtD
Trimipramine—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000213	0.00199	CcSEcCtD
Trimipramine—HTR1A—brain—Alzheimer's disease	0.000208	0.00348	CbGeAlD
Trimipramine—Diarrhoea—Donepezil—Alzheimer's disease	0.000208	0.00194	CcSEcCtD
Trimipramine—SLC6A2—brain—Alzheimer's disease	0.000206	0.00345	CbGeAlD
Trimipramine—Amitriptyline—NTRK2—Alzheimer's disease	0.000204	0.048	CrCbGaD
Trimipramine—Dizziness—Donepezil—Alzheimer's disease	0.000201	0.00187	CcSEcCtD
Trimipramine—Asthenia—Memantine—Alzheimer's disease	0.000198	0.00184	CcSEcCtD
Trimipramine—ABCB1—forebrain—Alzheimer's disease	0.000196	0.00328	CbGeAlD
Trimipramine—Pruritus—Memantine—Alzheimer's disease	0.000195	0.00182	CcSEcCtD
Trimipramine—HRH1—nervous system—Alzheimer's disease	0.000194	0.00325	CbGeAlD
Trimipramine—Asthenia—Rivastigmine—Alzheimer's disease	0.000193	0.0018	CcSEcCtD
Trimipramine—Vomiting—Donepezil—Alzheimer's disease	0.000193	0.0018	CcSEcCtD
Trimipramine—ADRA1A—brain—Alzheimer's disease	0.000192	0.00321	CbGeAlD
Trimipramine—Rash—Donepezil—Alzheimer's disease	0.000191	0.00179	CcSEcCtD
Trimipramine—Dermatitis—Donepezil—Alzheimer's disease	0.000191	0.00178	CcSEcCtD
Trimipramine—ADRA2A—nervous system—Alzheimer's disease	0.000191	0.00319	CbGeAlD
Trimipramine—Pruritus—Rivastigmine—Alzheimer's disease	0.000191	0.00178	CcSEcCtD
Trimipramine—Headache—Donepezil—Alzheimer's disease	0.00019	0.00177	CcSEcCtD
Trimipramine—Diarrhoea—Memantine—Alzheimer's disease	0.000188	0.00176	CcSEcCtD
Trimipramine—DRD2—brain—Alzheimer's disease	0.000188	0.00315	CbGeAlD
Trimipramine—Benazepril—MTHFR—Alzheimer's disease	0.000187	0.0441	CrCbGaD
Trimipramine—HRH1—central nervous system—Alzheimer's disease	0.000187	0.00313	CbGeAlD
Trimipramine—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000184	0.00172	CcSEcCtD
Trimipramine—ADRA2A—central nervous system—Alzheimer's disease	0.000184	0.00308	CbGeAlD
Trimipramine—Dizziness—Memantine—Alzheimer's disease	0.000182	0.0017	CcSEcCtD
Trimipramine—ABCB1—telencephalon—Alzheimer's disease	0.00018	0.00302	CbGeAlD
Trimipramine—Nausea—Donepezil—Alzheimer's disease	0.00018	0.00168	CcSEcCtD
Trimipramine—ADRA2A—cerebellum—Alzheimer's disease	0.00018	0.00301	CbGeAlD
Trimipramine—Dizziness—Rivastigmine—Alzheimer's disease	0.000178	0.00166	CcSEcCtD
Trimipramine—Vomiting—Memantine—Alzheimer's disease	0.000175	0.00163	CcSEcCtD
Trimipramine—Rash—Memantine—Alzheimer's disease	0.000174	0.00162	CcSEcCtD
Trimipramine—Dermatitis—Memantine—Alzheimer's disease	0.000173	0.00162	CcSEcCtD
Trimipramine—Headache—Memantine—Alzheimer's disease	0.000173	0.00161	CcSEcCtD
Trimipramine—Vomiting—Rivastigmine—Alzheimer's disease	0.000171	0.0016	CcSEcCtD
Trimipramine—Rash—Rivastigmine—Alzheimer's disease	0.00017	0.00159	CcSEcCtD
Trimipramine—Dermatitis—Rivastigmine—Alzheimer's disease	0.00017	0.00158	CcSEcCtD
Trimipramine—Headache—Rivastigmine—Alzheimer's disease	0.000169	0.00158	CcSEcCtD
Trimipramine—Nausea—Memantine—Alzheimer's disease	0.000164	0.00153	CcSEcCtD
Trimipramine—HTR2A—nervous system—Alzheimer's disease	0.000162	0.00272	CbGeAlD
Trimipramine—Nausea—Rivastigmine—Alzheimer's disease	0.00016	0.00149	CcSEcCtD
Trimipramine—HTR2A—central nervous system—Alzheimer's disease	0.000156	0.00262	CbGeAlD
Trimipramine—HTR2A—cerebellum—Alzheimer's disease	0.000153	0.00256	CbGeAlD
Trimipramine—Benazepril—ACE—Alzheimer's disease	0.000153	0.0359	CrCbGaD
Trimipramine—CYP3A4—nervous system—Alzheimer's disease	0.00015	0.00251	CbGeAlD
Trimipramine—HRH1—brain—Alzheimer's disease	0.000149	0.00249	CbGeAlD
Trimipramine—Mianserin—HTR6—Alzheimer's disease	0.000148	0.0349	CrCbGaD
Trimipramine—CYP2D6—nervous system—Alzheimer's disease	0.000148	0.00247	CbGeAlD
Trimipramine—ADRA2A—brain—Alzheimer's disease	0.000146	0.00244	CbGeAlD
Trimipramine—CYP3A4—central nervous system—Alzheimer's disease	0.000145	0.00242	CbGeAlD
Trimipramine—CYP2D6—central nervous system—Alzheimer's disease	0.000142	0.00238	CbGeAlD
Trimipramine—CYP2D6—cerebellum—Alzheimer's disease	0.000139	0.00233	CbGeAlD
Trimipramine—Clomipramine—HTR6—Alzheimer's disease	0.000136	0.0319	CrCbGaD
Trimipramine—Promethazine—CALM1—Alzheimer's disease	0.000133	0.0313	CrCbGaD
Trimipramine—Nortriptyline—HTR6—Alzheimer's disease	0.000132	0.0312	CrCbGaD
Trimipramine—HTR2A—brain—Alzheimer's disease	0.000124	0.00208	CbGeAlD
Trimipramine—Doxepin—HTR6—Alzheimer's disease	0.000119	0.028	CrCbGaD
Trimipramine—Ethopropazine—BCHE—Alzheimer's disease	0.000115	0.0272	CrCbGaD
Trimipramine—CYP2D6—brain—Alzheimer's disease	0.000113	0.00189	CbGeAlD
Trimipramine—ABCB1—nervous system—Alzheimer's disease	0.000106	0.00178	CbGeAlD
Trimipramine—Chlorpromazine—CALM1—Alzheimer's disease	0.000103	0.0243	CrCbGaD
Trimipramine—ABCB1—central nervous system—Alzheimer's disease	0.000102	0.00171	CbGeAlD
Trimipramine—ABCB1—cerebellum—Alzheimer's disease	0.0001	0.00168	CbGeAlD
Trimipramine—Chlorpromazine—HTR6—Alzheimer's disease	9.3e-05	0.0219	CrCbGaD
Trimipramine—Imipramine—HTR6—Alzheimer's disease	9.25e-05	0.0218	CrCbGaD
Trimipramine—Amitriptyline—HTR6—Alzheimer's disease	9.19e-05	0.0216	CrCbGaD
Trimipramine—Cyamemazine—HTR2A—Alzheimer's disease	8.17e-05	0.0192	CrCbGaD
Trimipramine—Aprindine—CYP2D6—Alzheimer's disease	8.17e-05	0.0192	CrCbGaD
Trimipramine—ABCB1—brain—Alzheimer's disease	8.13e-05	0.00136	CbGeAlD
Trimipramine—Cyclobenzaprine—HTR2A—Alzheimer's disease	7.59e-05	0.0179	CrCbGaD
Trimipramine—Epinastine—HTR2A—Alzheimer's disease	7.54e-05	0.0177	CrCbGaD
Trimipramine—Cyclobenzaprine—CYP2D6—Alzheimer's disease	6.94e-05	0.0163	CrCbGaD
Trimipramine—Epinastine—CYP2D6—Alzheimer's disease	6.89e-05	0.0162	CrCbGaD
Trimipramine—Mequitazine—CYP2D6—Alzheimer's disease	6.49e-05	0.0153	CrCbGaD
Trimipramine—Mianserin—SLC6A4—Alzheimer's disease	5.67e-05	0.0134	CrCbGaD
Trimipramine—Acepromazine—HTR2A—Alzheimer's disease	5.25e-05	0.0123	CrCbGaD
Trimipramine—Nortriptyline—PTGS1—Alzheimer's disease	5.24e-05	0.0123	CrCbGaD
Trimipramine—Clomipramine—SLC6A4—Alzheimer's disease	5.19e-05	0.0122	CrCbGaD
Trimipramine—Nortriptyline—SLC6A4—Alzheimer's disease	5.07e-05	0.0119	CrCbGaD
Trimipramine—Diphenhydramine—PTGS1—Alzheimer's disease	4.84e-05	0.0114	CrCbGaD
Trimipramine—Dextropropoxyphene—CYP2D6—Alzheimer's disease	4.69e-05	0.011	CrCbGaD
Trimipramine—Chlorpromazine—BCHE—Alzheimer's disease	4.56e-05	0.0107	CrCbGaD
Trimipramine—Doxepin—SLC6A4—Alzheimer's disease	4.55e-05	0.0107	CrCbGaD
Trimipramine—Mianserin—HTR2A—Alzheimer's disease	4.36e-05	0.0103	CrCbGaD
Trimipramine—Propiomazine—HTR2A—Alzheimer's disease	4.19e-05	0.00987	CrCbGaD
Trimipramine—Desipramine—SLC6A4—Alzheimer's disease	4.18e-05	0.00983	CrCbGaD
Trimipramine—Clomipramine—HTR2A—Alzheimer's disease	3.99e-05	0.00939	CrCbGaD
Trimipramine—Mianserin—CYP2D6—Alzheimer's disease	3.99e-05	0.00939	CrCbGaD
Trimipramine—Nortriptyline—HTR2A—Alzheimer's disease	3.9e-05	0.00917	CrCbGaD
Trimipramine—Clomipramine—CYP2D6—Alzheimer's disease	3.65e-05	0.00858	CrCbGaD
Trimipramine—Methotrimeprazine—HTR2A—Alzheimer's disease	3.59e-05	0.00844	CrCbGaD
Trimipramine—Nortriptyline—CYP2D6—Alzheimer's disease	3.56e-05	0.00839	CrCbGaD
Trimipramine—Imipramine—SLC6A4—Alzheimer's disease	3.54e-05	0.00833	CrCbGaD
Trimipramine—Promethazine—HTR2A—Alzheimer's disease	3.53e-05	0.00832	CrCbGaD
Trimipramine—Amitriptyline—SLC6A4—Alzheimer's disease	3.52e-05	0.00828	CrCbGaD
Trimipramine—Doxepin—HTR2A—Alzheimer's disease	3.5e-05	0.00823	CrCbGaD
Trimipramine—Diphenhydramine—CYP2D6—Alzheimer's disease	3.3e-05	0.00776	CrCbGaD
Trimipramine—Methotrimeprazine—CYP2D6—Alzheimer's disease	3.28e-05	0.00772	CrCbGaD
Trimipramine—Promethazine—CYP2D6—Alzheimer's disease	3.23e-05	0.0076	CrCbGaD
Trimipramine—Desipramine—HTR2A—Alzheimer's disease	3.21e-05	0.00755	CrCbGaD
Trimipramine—Doxepin—CYP2D6—Alzheimer's disease	3.2e-05	0.00753	CrCbGaD
Trimipramine—Methadone—CYP2D6—Alzheimer's disease	3.18e-05	0.00749	CrCbGaD
Trimipramine—Promazine—HTR2A—Alzheimer's disease	3.11e-05	0.00732	CrCbGaD
Trimipramine—Desipramine—CYP2D6—Alzheimer's disease	2.93e-05	0.00691	CrCbGaD
Trimipramine—Chlorpromazine—HTR2A—Alzheimer's disease	2.74e-05	0.00644	CrCbGaD
Trimipramine—Imipramine—HTR2A—Alzheimer's disease	2.72e-05	0.0064	CrCbGaD
Trimipramine—Amitriptyline—HTR2A—Alzheimer's disease	2.7e-05	0.00637	CrCbGaD
Trimipramine—Chlorpromazine—CYP2D6—Alzheimer's disease	2.5e-05	0.00589	CrCbGaD
Trimipramine—Imipramine—CYP2D6—Alzheimer's disease	2.49e-05	0.00586	CrCbGaD
Trimipramine—Amitriptyline—CYP2D6—Alzheimer's disease	2.47e-05	0.00582	CrCbGaD
Trimipramine—ADRA2A—Signaling Pathways—CCR5—Alzheimer's disease	3.4e-06	5.27e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—LEP—Alzheimer's disease	3.39e-06	5.26e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—APOE—Alzheimer's disease	3.39e-06	5.26e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—GSK3B—Alzheimer's disease	3.39e-06	5.26e-05	CbGpPWpGaD
Trimipramine—HTR1D—GPCR downstream signaling—AKT1—Alzheimer's disease	3.38e-06	5.25e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—CREB1—Alzheimer's disease	3.38e-06	5.24e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—IGF1—Alzheimer's disease	3.37e-06	5.22e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CAV1—Alzheimer's disease	3.36e-06	5.22e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—CREB1—Alzheimer's disease	3.36e-06	5.22e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—INS—Alzheimer's disease	3.36e-06	5.21e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CAV1—Alzheimer's disease	3.36e-06	5.21e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—CASP3—Alzheimer's disease	3.35e-06	5.2e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	3.35e-06	5.2e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—INS—Alzheimer's disease	3.34e-06	5.19e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CALM1—Alzheimer's disease	3.34e-06	5.18e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—HMOX1—Alzheimer's disease	3.33e-06	5.17e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—IL6—Alzheimer's disease	3.33e-06	5.17e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—LEP—Alzheimer's disease	3.33e-06	5.16e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—APOE—Alzheimer's disease	3.33e-06	5.16e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—HTR2A—Alzheimer's disease	3.32e-06	5.16e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—CCL2—Alzheimer's disease	3.3e-06	5.13e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—ESR1—Alzheimer's disease	3.3e-06	5.12e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CAV1—Alzheimer's disease	3.29e-06	5.11e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—CCL2—Alzheimer's disease	3.29e-06	5.1e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—F2—Alzheimer's disease	3.26e-06	5.05e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—IGF1—Alzheimer's disease	3.25e-06	5.04e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—ESR1—Alzheimer's disease	3.24e-06	5.03e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—GSK3B—Alzheimer's disease	3.24e-06	5.03e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—ESR1—Alzheimer's disease	3.24e-06	5.02e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—IGF1—Alzheimer's disease	3.23e-06	5.02e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—PPARG—Alzheimer's disease	3.22e-06	5e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—CREB1—Alzheimer's disease	3.22e-06	4.99e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—F2—Alzheimer's disease	3.2e-06	4.97e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—INS—Alzheimer's disease	3.2e-06	4.96e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—F2—Alzheimer's disease	3.2e-06	4.96e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—NOTCH1—Alzheimer's disease	3.19e-06	4.94e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—ESR1—Alzheimer's disease	3.17e-06	4.93e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—INS—Alzheimer's disease	3.16e-06	4.9e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	3.16e-06	4.9e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—CCL2—Alzheimer's disease	3.15e-06	4.88e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	3.14e-06	4.88e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Hemostasis—AKT1—Alzheimer's disease	3.14e-06	4.87e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—F2—Alzheimer's disease	3.14e-06	4.87e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—NOTCH1—Alzheimer's disease	3.13e-06	4.87e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	3.13e-06	4.86e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—NOTCH1—Alzheimer's disease	3.13e-06	4.85e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—LPL—Alzheimer's disease	3.12e-06	4.85e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	3.11e-06	4.83e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CALM1—Alzheimer's disease	3.1e-06	4.81e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—IGF1—Alzheimer's disease	3.09e-06	4.8e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—LEP—Alzheimer's disease	3.09e-06	4.8e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—APOE—Alzheimer's disease	3.09e-06	4.8e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—MAPK8—Alzheimer's disease	3.08e-06	4.78e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling by GPCR—AKT1—Alzheimer's disease	3.07e-06	4.77e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—NOTCH1—Alzheimer's disease	3.07e-06	4.76e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CAV1—Alzheimer's disease	3.06e-06	4.75e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—NOS3—Alzheimer's disease	3.05e-06	4.74e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—LPL—Alzheimer's disease	3.05e-06	4.73e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—ACHE—Alzheimer's disease	3e-06	4.66e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—GSK3B—Alzheimer's disease	2.99e-06	4.64e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	2.97e-06	4.61e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CREB1—Alzheimer's disease	2.97e-06	4.6e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—ESR1—Alzheimer's disease	2.95e-06	4.58e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—INS—Alzheimer's disease	2.95e-06	4.58e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—NOS3—Alzheimer's disease	2.95e-06	4.57e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—GSK3B—Alzheimer's disease	2.94e-06	4.57e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—GSK3B—Alzheimer's disease	2.93e-06	4.56e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—NOS3—Alzheimer's disease	2.93e-06	4.55e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CREB1—Alzheimer's disease	2.92e-06	4.53e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—F2—Alzheimer's disease	2.91e-06	4.52e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CREB1—Alzheimer's disease	2.91e-06	4.52e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—INS—Alzheimer's disease	2.9e-06	4.5e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CCL2—Alzheimer's disease	2.9e-06	4.5e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—INS—Alzheimer's disease	2.9e-06	4.49e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—GSK3B—Alzheimer's disease	2.88e-06	4.47e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—LPL—Alzheimer's disease	2.87e-06	4.46e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CREB1—Alzheimer's disease	2.86e-06	4.43e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CCL2—Alzheimer's disease	2.85e-06	4.43e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—IGF1—Alzheimer's disease	2.85e-06	4.43e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—NOTCH1—Alzheimer's disease	2.85e-06	4.43e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CCL2—Alzheimer's disease	2.85e-06	4.42e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—LPL—Alzheimer's disease	2.85e-06	4.42e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—VEGFA—Alzheimer's disease	2.84e-06	4.42e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—INS—Alzheimer's disease	2.84e-06	4.41e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—ENO1—Alzheimer's disease	2.81e-06	4.37e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	2.81e-06	4.37e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	2.81e-06	4.37e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—IGF1—Alzheimer's disease	2.81e-06	4.36e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—NOS3—Alzheimer's disease	2.8e-06	4.35e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—IGF1—Alzheimer's disease	2.8e-06	4.35e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CCL2—Alzheimer's disease	2.8e-06	4.34e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—NOS3—Alzheimer's disease	2.77e-06	4.3e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	2.76e-06	4.28e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—IGF1—Alzheimer's disease	2.75e-06	4.27e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—MTHFR—Alzheimer's disease	2.74e-06	4.26e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—GSK3B—Alzheimer's disease	2.68e-06	4.15e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CREB1—Alzheimer's disease	2.65e-06	4.12e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—INS—Alzheimer's disease	2.64e-06	4.1e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—CALM1—Alzheimer's disease	2.63e-06	4.08e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—APOE—Alzheimer's disease	2.62e-06	4.06e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—BCHE—Alzheimer's disease	2.62e-06	4.06e-05	CbGpPWpGaD
Trimipramine—ADRA2B—GPCR downstream signaling—AKT1—Alzheimer's disease	2.61e-06	4.06e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—TGFB1—Alzheimer's disease	2.61e-06	4.05e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CCL2—Alzheimer's disease	2.6e-06	4.03e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—CAV1—Alzheimer's disease	2.59e-06	4.03e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—CASP3—Alzheimer's disease	2.59e-06	4.02e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	2.59e-06	4.01e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—NOS3—Alzheimer's disease	2.59e-06	4.01e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—IL6—Alzheimer's disease	2.57e-06	3.99e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—CALM1—Alzheimer's disease	2.56e-06	3.98e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	2.56e-06	3.98e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—APOE—Alzheimer's disease	2.56e-06	3.97e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—IGF1—Alzheimer's disease	2.55e-06	3.96e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—NOS3—Alzheimer's disease	2.54e-06	3.95e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—NOS3—Alzheimer's disease	2.54e-06	3.94e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—PTGS2—Alzheimer's disease	2.53e-06	3.93e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—CAV1—Alzheimer's disease	2.53e-06	3.93e-05	CbGpPWpGaD
Trimipramine—HTR1A—GPCR downstream signaling—AKT1—Alzheimer's disease	2.52e-06	3.92e-05	CbGpPWpGaD
Trimipramine—HTR2C—GPCR downstream signaling—AKT1—Alzheimer's disease	2.51e-06	3.9e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—CASP3—Alzheimer's disease	2.5e-06	3.88e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—NOS3—Alzheimer's disease	2.49e-06	3.87e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—CASP3—Alzheimer's disease	2.49e-06	3.86e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—IL6—Alzheimer's disease	2.48e-06	3.86e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—IL6—Alzheimer's disease	2.47e-06	3.84e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	2.47e-06	3.83e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—CALM1—Alzheimer's disease	2.42e-06	3.75e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—APOE—Alzheimer's disease	2.41e-06	3.74e-05	CbGpPWpGaD
Trimipramine—ADRA1B—GPCR downstream signaling—AKT1—Alzheimer's disease	2.4e-06	3.73e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—CALM1—Alzheimer's disease	2.4e-06	3.72e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	2.39e-06	3.72e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—APOE—Alzheimer's disease	2.39e-06	3.71e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—CAV1—Alzheimer's disease	2.39e-06	3.7e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—CASP3—Alzheimer's disease	2.38e-06	3.7e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—MAPK8—Alzheimer's disease	2.38e-06	3.7e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling by GPCR—AKT1—Alzheimer's disease	2.37e-06	3.69e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—IL6—Alzheimer's disease	2.37e-06	3.67e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—CAV1—Alzheimer's disease	2.37e-06	3.67e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—NOS3—Alzheimer's disease	2.31e-06	3.59e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—MAPK8—Alzheimer's disease	2.3e-06	3.57e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling by GPCR—AKT1—Alzheimer's disease	2.29e-06	3.56e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—MAPK8—Alzheimer's disease	2.29e-06	3.55e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PPARG—Alzheimer's disease	2.28e-06	3.54e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling by GPCR—AKT1—Alzheimer's disease	2.28e-06	3.54e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—INS—Alzheimer's disease	2.24e-06	3.47e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PPARG—Alzheimer's disease	2.23e-06	3.45e-05	CbGpPWpGaD
Trimipramine—DRD2—GPCR downstream signaling—AKT1—Alzheimer's disease	2.22e-06	3.44e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—VEGFA—Alzheimer's disease	2.2e-06	3.41e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—CASP3—Alzheimer's disease	2.2e-06	3.41e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—MAPK8—Alzheimer's disease	2.19e-06	3.4e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—INS—Alzheimer's disease	2.18e-06	3.39e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling by GPCR—AKT1—Alzheimer's disease	2.18e-06	3.39e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—IL6—Alzheimer's disease	2.18e-06	3.39e-05	CbGpPWpGaD
Trimipramine—HTR2A—GPCR downstream signaling—AKT1—Alzheimer's disease	2.18e-06	3.38e-05	CbGpPWpGaD
Trimipramine—HRH1—GPCR downstream signaling—AKT1—Alzheimer's disease	2.18e-06	3.38e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—CASP3—Alzheimer's disease	2.16e-06	3.35e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—CASP3—Alzheimer's disease	2.16e-06	3.35e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—TP53—Alzheimer's disease	2.15e-06	3.34e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—IL6—Alzheimer's disease	2.15e-06	3.33e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—IL6—Alzheimer's disease	2.14e-06	3.32e-05	CbGpPWpGaD
Trimipramine—ADRA1A—GPCR downstream signaling—AKT1—Alzheimer's disease	2.13e-06	3.31e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—VEGFA—Alzheimer's disease	2.12e-06	3.29e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—CASP3—Alzheimer's disease	2.12e-06	3.28e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—VEGFA—Alzheimer's disease	2.11e-06	3.28e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—IL6—Alzheimer's disease	2.1e-06	3.26e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PPARG—Alzheimer's disease	2.1e-06	3.26e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PPARG—Alzheimer's disease	2.08e-06	3.23e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	2.06e-06	3.2e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—INS—Alzheimer's disease	2.06e-06	3.19e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	2.05e-06	3.19e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—INS—Alzheimer's disease	2.04e-06	3.17e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—VEGFA—Alzheimer's disease	2.02e-06	3.14e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—MAPK8—Alzheimer's disease	2.02e-06	3.13e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—TGFB1—Alzheimer's disease	2.02e-06	3.13e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling by GPCR—AKT1—Alzheimer's disease	2.01e-06	3.12e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—MAPK8—Alzheimer's disease	1.99e-06	3.08e-05	CbGpPWpGaD
Trimipramine—ADRA2A—GPCR downstream signaling—AKT1—Alzheimer's disease	1.98e-06	3.08e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—MAPK8—Alzheimer's disease	1.98e-06	3.08e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling by GPCR—AKT1—Alzheimer's disease	1.98e-06	3.07e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling by GPCR—AKT1—Alzheimer's disease	1.98e-06	3.07e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—IL6—Alzheimer's disease	1.97e-06	3.05e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—CASP3—Alzheimer's disease	1.97e-06	3.05e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—NOS3—Alzheimer's disease	1.96e-06	3.04e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—IL6—Alzheimer's disease	1.95e-06	3.03e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—TGFB1—Alzheimer's disease	1.95e-06	3.02e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—MAPK8—Alzheimer's disease	1.94e-06	3.02e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling by GPCR—AKT1—Alzheimer's disease	1.94e-06	3.01e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—TGFB1—Alzheimer's disease	1.94e-06	3.01e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—NOS3—Alzheimer's disease	1.91e-06	2.97e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.88e-06	2.92e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—VEGFA—Alzheimer's disease	1.86e-06	2.89e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—TGFB1—Alzheimer's disease	1.85e-06	2.88e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—VEGFA—Alzheimer's disease	1.83e-06	2.85e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—VEGFA—Alzheimer's disease	1.83e-06	2.84e-05	CbGpPWpGaD
Trimipramine—HTR1D—Signaling Pathways—AKT1—Alzheimer's disease	1.82e-06	2.82e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—MAPK8—Alzheimer's disease	1.81e-06	2.8e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—NOS3—Alzheimer's disease	1.8e-06	2.8e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling by GPCR—AKT1—Alzheimer's disease	1.8e-06	2.8e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—VEGFA—Alzheimer's disease	1.79e-06	2.79e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	1.79e-06	2.78e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—NOS3—Alzheimer's disease	1.79e-06	2.78e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—PTGS2—Alzheimer's disease	1.75e-06	2.72e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—TGFB1—Alzheimer's disease	1.71e-06	2.65e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	1.69e-06	2.62e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—TGFB1—Alzheimer's disease	1.68e-06	2.61e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—TGFB1—Alzheimer's disease	1.68e-06	2.61e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—VEGFA—Alzheimer's disease	1.67e-06	2.59e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—TP53—Alzheimer's disease	1.66e-06	2.58e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	1.65e-06	2.56e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—TGFB1—Alzheimer's disease	1.65e-06	2.56e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	1.64e-06	2.54e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—TP53—Alzheimer's disease	1.6e-06	2.49e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—TP53—Alzheimer's disease	1.59e-06	2.48e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—CALM1—Alzheimer's disease	1.58e-06	2.45e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—APOE—Alzheimer's disease	1.57e-06	2.44e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—CAV1—Alzheimer's disease	1.56e-06	2.42e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—TGFB1—Alzheimer's disease	1.53e-06	2.38e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—TP53—Alzheimer's disease	1.53e-06	2.37e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—IL6—Alzheimer's disease	1.52e-06	2.36e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—IL6—Alzheimer's disease	1.47e-06	2.28e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—IL6—Alzheimer's disease	1.46e-06	2.27e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—TP53—Alzheimer's disease	1.41e-06	2.19e-05	CbGpPWpGaD
Trimipramine—ADRA2B—Signaling Pathways—AKT1—Alzheimer's disease	1.4e-06	2.18e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—IL6—Alzheimer's disease	1.4e-06	2.17e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—TP53—Alzheimer's disease	1.39e-06	2.15e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—TP53—Alzheimer's disease	1.38e-06	2.15e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PPARG—Alzheimer's disease	1.37e-06	2.13e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—TP53—Alzheimer's disease	1.36e-06	2.11e-05	CbGpPWpGaD
Trimipramine—HTR1A—Signaling Pathways—AKT1—Alzheimer's disease	1.35e-06	2.1e-05	CbGpPWpGaD
Trimipramine—HTR2C—Signaling Pathways—AKT1—Alzheimer's disease	1.35e-06	2.09e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—INS—Alzheimer's disease	1.34e-06	2.09e-05	CbGpPWpGaD
Trimipramine—ADRA1B—Signaling Pathways—AKT1—Alzheimer's disease	1.29e-06	2e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—IL6—Alzheimer's disease	1.29e-06	2e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Metabolism—AKT1—Alzheimer's disease	1.27e-06	1.98e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—IL6—Alzheimer's disease	1.27e-06	1.97e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—IL6—Alzheimer's disease	1.27e-06	1.96e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—TP53—Alzheimer's disease	1.26e-06	1.96e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—IL6—Alzheimer's disease	1.24e-06	1.93e-05	CbGpPWpGaD
Trimipramine—DRD2—Signaling Pathways—AKT1—Alzheimer's disease	1.19e-06	1.85e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—NOS3—Alzheimer's disease	1.18e-06	1.83e-05	CbGpPWpGaD
Trimipramine—HTR2A—Signaling Pathways—AKT1—Alzheimer's disease	1.17e-06	1.82e-05	CbGpPWpGaD
Trimipramine—HRH1—Signaling Pathways—AKT1—Alzheimer's disease	1.17e-06	1.81e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—IL6—Alzheimer's disease	1.15e-06	1.79e-05	CbGpPWpGaD
Trimipramine—ADRA1A—Signaling Pathways—AKT1—Alzheimer's disease	1.15e-06	1.78e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	1.08e-06	1.67e-05	CbGpPWpGaD
Trimipramine—ADRA2A—Signaling Pathways—AKT1—Alzheimer's disease	1.06e-06	1.65e-05	CbGpPWpGaD
Trimipramine—CYP2C19—Metabolism—AKT1—Alzheimer's disease	9.02e-07	1.4e-05	CbGpPWpGaD
Trimipramine—ABCB1—Metabolism—AKT1—Alzheimer's disease	8.8e-07	1.37e-05	CbGpPWpGaD
Trimipramine—CYP2D6—Metabolism—AKT1—Alzheimer's disease	8.29e-07	1.29e-05	CbGpPWpGaD
Trimipramine—CYP2C9—Metabolism—AKT1—Alzheimer's disease	8.22e-07	1.28e-05	CbGpPWpGaD
Trimipramine—CYP3A4—Metabolism—AKT1—Alzheimer's disease	5.42e-07	8.42e-06	CbGpPWpGaD
